Former NFL All-Pro running back Chris Johnson has been diagnosed with amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. The announcement was shared via a video posted to Johnson’s official social media accounts and reported by RDS, confirming the diagnosis for the former Tennessee Titans star.
Who is Chris Johnson and what is his diagnosis?
Chris Johnson, known as “CJ2K” for his record-breaking speed and agility, is a retired NFL running back who played from 2008 to 2015. According to the report from RDS, Johnson is battling ALS, a condition commonly referred to as Lou Gehrig’s disease. ALS causes the motor neurons that control voluntary muscles to degenerate, eventually leading to muscle weakness, atrophy, and failure of the respiratory system.
In the video shared by Johnson, he spoke directly to his followers about the diagnosis, emphasizing a desire to raise awareness for the disease and the challenges associated with it. While the specific stage of his progression was not detailed in the announcement, the nature of ALS is characterized by a steady decline in physical mobility.
What are the implications of ALS for former athletes?
The diagnosis of a high-profile athlete like Johnson brings renewed attention to the prevalence of neurodegenerative diseases among former professional football players. While ALS is distinct from Chronic Traumatic Encephalopathy (CTE)—which is linked to repeated head trauma—medical researchers continue to study whether there is a correlation between professional contact sports and the onset of motor neuron diseases.

For a player whose career was defined by elite athleticism and explosive speed, the loss of motor function presents a profound physical and psychological transition. Johnson once held the NFL record for the most rushing yards in a single season (2,024 yards in 2009), a feat that required peak neurological and muscular coordination.
Chris Johnson’s NFL career and legacy
Johnson entered the NFL as a second-round pick for the Tennessee Titans in 2008. He quickly became one of the most dangerous offensive weapons in league history due to his acceleration. According to NFL official records, Johnson’s 2009 season remains one of the most dominant individual performances by a running back, earning him a First-team All-Pro selection and a Pro Bowl nod.
Over the course of his career, which included stints with the Titans, the Arizona Cardinals, and the New York Jets, Johnson amassed over 10,000 rushing yards. His ability to score from anywhere on the field made him a centerpiece of the Titans’ offense for several years.
How is the community responding to the news?
Following the announcement, a wave of support from former teammates, NFL analysts, and fans has emerged across social media platforms. Many have pointed to Johnson’s openness about his condition as a way to help others recognize the early symptoms of ALS, which can often be mistaken for general aging or unrelated injuries.
Advocacy groups for ALS typically encourage patients to share their stories to drive funding for research and to improve the quality of care for those living with the disease. By using his platform, Johnson is directing global attention toward the need for a cure and better supportive therapies.
What happens next for Chris Johnson?
There is currently no known cure for ALS, but various treatments can help manage symptoms and prolong life. Johnson’s public announcement serves as a starting point for his journey in advocating for the disease. There are no scheduled public appearances or official foundation launches announced at this time, but his social media channels remain the primary source for updates on his health and any charitable initiatives he may lead.
For those seeking more information on the disease or looking to support ALS research, official resources such as the ALS Association provide comprehensive guides on care and current clinical trials.
Follow Archysport for further updates on this story as more information becomes available.
Keep reading